Abstract
The effect of vitamin D3 analogues on endotoxin shock in mice was investigated. Male ICR mice were orally administered vitamin D3 analogues or vehicle, accompanied by an intraperitoneal injection of endotoxin (E. Coli lipopolysaccharide, LPS, 20 mg/kg). Endotoxin caused a decrease in survival rate in a time-dependent manner. Increases in plasma immunoreactive (i) eicosanoid and hepatic malondialdehyde (MDA) levels were also observed. Administration of 1α-hydroxyvitamin D3 (1α-OH-D3) improved the survival rate 24 to 48 h after endotoxin treatment. The effects were markedly observed at a dose of 20 ng/kg. In addition, 1α-OH-D3 restored the plasma iTXB2 and hepatic MDA levels 8 h after endotoxin injection. However, it did not affect plasma iPGE2, i6-keto-PGF1α and blood iLTB4 levels. At a dose of 20 ng/kg, both 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) and 1,24(R)-dihydroxyvitamin D3 (1,24(R)-(OH)2D3) restored the survival rate, the plasma iTXB2 and hepatic MDA levels. These results suggest that vitamin D3 analogues may inhibit endotoxemia through regulation of the formation of TXA2 and free radicals.
Similar content being viewed by others
References
D. C. Morrison and S. Raziuddin,Lipopolysaccharides and endotoxin. InImmunophamacology. (Eds. P. Sirois and M. Rola-Plwszczynski) pp. 169–199, Elsevier Biomedical Press, Amsterdam 1982.
G. D. Bottoms, M. A. Johnson, C. H. Lamer, J. F. Fessler and J. J. Turek,Endotoxin-induced eicosanoid production by equine vascular endothelial cells and neutrophils. Circ. Shock15, 155–162 (1985).
W. Hagmann, C. Denzlinger and D. Keppler,Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action. Circ. Shock14, 223–235 (1984).
L. S. Olanoff, J. A. Cook, T. Eller, D. R. Knapp and P. V. Halushka,Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia. J. Cardiovasc. Pharmacol.7, 114–120 (1985).
K. F. Badr, V. E. Kelley, H. G. Rennke and B. M. Brenner,Role for thromboxane A 2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int.30, 474–480 (1986).
M. L. Ogretree, C. J. Begley, G. A. King and K. L. Brigham,Influence of steroidal and nonsteroidal anti-inflammatory agents on the accumulation of arachidonic acid metabolites in plasma and lung lymph after endotoxemia in awake sheep. Am. Rev. Respir. Dis.133, 55–61 (1986).
G. Matera, J. A. Cook, R. A. Hennigar, G. E. Tempel, W. C. Wise, T. D. Oglesby and P. V. Halushka,Beneficial effects of a 5-lipoxygenase inhibitor in endotoxic shock in the rat. J. Pharmacol. Exp. Ther.247, 363–371 (1988).
R. Ogawa, T. Morita, F. Kunimoto and T. Fujita,Changes in hepatic lipoperoxide concentration in endotoxemic rats. Circ. Shock9, 369–374 (1982).
K. Sugino, K. Dohi, K. Yamada and T. Kawasaki,The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery101, 746–752 (1987).
E. Abe, C. Miyaura, H. Sakagami, M. Takeda, K. Konno, T. Yamazaki, S. Yoshiki and T. Suda,Differentiation of mouse myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D 3. Proc. Natl. Acad. Sci. USA78, 4990–4994 (1981).
C. Miyaura, E. Abe, T. Kuribayashi, H. Tanaka, K. Konno, Y. Nishii and T. Suda,1α,25-Dihydroxyvitamin D 3 induces differentiation of human myeloid leukemia cells. Biochem. Biophys. Res. Commun.102, 937–943 (1981).
I. Olsson, U. Gullberg, I. Ivhed and K. Nilsson,Induction of differentiation of the human histocytic lymphoma cell line U-937 by 1α,25-dihydroxycholecalciferol. Cancer Res.43, 5862–5867 (1983).
H. P. Koeffler, T. Amatruda, N. Ikekawa, Y. Kobayashi and H. F. DeLuca,Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D 3 and its fluorinated analogues. Cancer Res.44, 5624–5628 (1984).
E. P. Amento, A. K. Bhalla, J. T. Kurnick, R. L. Kradin, T. L. Clemens, S. A. Holick, M. F. Holick and S. M. Krane,1α,25-Dihydroxyvitamin D 3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokines, mononuclear cell factor. J. Clin. Invest.73, 731–739 (1984).
A. K. Bhalla, E. P. Amento and S. M. Krane,Differential effects of 1,25-dihydroxyvitamin D 3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell. Immunol.98, 311–322 (1986).
M. S. Cohen, D. E. Mesler, R. G. Snipes and T. K. Gray,1,25-Dihydroxyvitamin D 3 activates secretion of hydrogen peroxide by human monocytes. J. Immunol.136, 1049–1053 (1986).
S. Iho, F. Kura, H. Sugiyama, T. Takahashi and T. Hoshino,The role of monocytes in the suppression of PHA-induced proliferation and IL 2 production of human mononuclear cells by 1,25-dihydroxyvitamin D 3. Immunol. Lett.11, 331–336 (1985).
C. D. Tsoukas, D. Watry, S. S. Escobar, D. M. Provvedini, C. A. Dinarello, F. G. Hustmyer and S. C. Manolagas,Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D 3. J. Clin. Endocrinol. Metab.69, 127–133 (1989).
H. Ohkawa, N. Ohishi and K. Yagi,Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem.95, 351–358 (1979).
M. J. Pabst and R. B. Johnston, Jr.,Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J. Exp. Med.151, 101–114 (1980).
A. R. Etemadi, G. E. Tempel, B. A. Farah, W. C. Wise, P. V. Halushka and J. A. Cook,Beneficial effects of a leukotriene antagonist on endotoxin-induced acute hemodynamic alterations. Circ. Shock22, 55–63 (1987).
T. Yoshikawa, M. Murakami, O. Seto, Y. Kakimi, T. Takemura, T. Tanigawa, S. Sugino and M. Kondo,Effects of superoxide dismutase and catalase on endotoxin shock in rats. J. Clin. Biochem. Nutr.1, 165–170 (1986).
M. Karasawa, J. Hosoi, H. Hashiba, K. Nose, C. Tohyama, E. Abe, T. Suda and T. Kuroki,Regulation of metallothionein gene expression by 1α,25-dihydroxyvitamin D 3 in cultured cells and in mice. Proc. Natl. Acad. Sci. USA84, 8810–8813 (1987).
B. S. Polla, A. M. Healy, E. P. Amento and S. M. Krane,1,25-Dihydroxyvitamin D 3 maintains adherence of human monocytes and protects them from thermal injury. J. Clin. Invest.77, 1332–1339 (1986).
B. S. Polla, A. M. Healy, W. C. Wojno and S. M. Krane,Hormone 1α,25-dihydroxyvitamin D 3 modulates heat shock response in monocytes. Am. J. Physiol.252, C640-C649 (1987).
P. J. Thornalley and M. Vasák,Possible role of metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim. Biophys. Acta827, 36–44 (1985).
M. F. Holick, S. A. Holick, T. Tavela, B. Gallagher, K. H. Schnones and H. F. DeLuca,Synthesis of [6-3 H]-1α-hydroxyvitamin D and its metabolism in vivo to [6-3H]-1α,25-dihydroxyvitamin D. Science190, 576–578 (1975).
M. Fukushima, Y. Suzuki, Y. Tohira, I. Matsunaga, K. Ochi, H. Nagano, Y. Nishii and T. Suda,Metabolism of 1α-hydroxyvitamin D to 1α,25-dihydroxyvitamin D in perfused rat liver. Biochem. Biophys. Res. Commun.66, 632–638 (1975).
S. Ishizuka, K. Bannai, T. Naruchi and Y. Hashimoto,Studies on the mechanism of action of 1α,24-dihydroxyvitamin D 3 II. Specific binding of 1α,24-dihydroxyvitamin D 3 to chick intestinal receptor. Steroids37, 33–43 (1981).
K. Matsumoto, K. Hashimoto, M. Kiyoki, M. Yamamoto and K. Yoshikawa,Effect of 1,24R-dihidroxyvitamin D 3 on the growth of human keratinocytes. J. Dermatol.17, 97–103 (1990).
H. Kawashima, K. Hoshina, Y. Hashimoto, T. Takeshita, S. Ishimoto, T. Noguchi, N. Ikekawa, M. Morisaki and H. Orimo,Biological activity of 1α,24-dihydroxycholecalciferol; A new synthetic analog of the hormonal form of vitamin D. FEBS Lett.76, 177–181 (1977).
K. Komoriya, I. Nagata, M. Tsuchimoto, K. Kunisawa, T. Takeshita and T. Naruchi,1,25-Dihydroxyvitamin D 3 and 1,24-dihydroxyvitamin D 3 suppress in vitro antibody response to T cell-dependent antigen. Biochem. Biophys. Res. Commun.127, 753–758 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Horiuchi, H., Nagata, I. & Komoriya, K. Protective effect of vitamin D3 analogues on endotoxin shock in mice. Agents and Actions 33, 343–348 (1991). https://doi.org/10.1007/BF01986584
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01986584